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We analyzed the steroid sulfatase (STS) gene in nine 
Japanese patients with X-linked ichthyosis (XLI) by a 
polymerase chain reaction technique and subsequent 
DNA sequencing. Eight of nine patients showed 
complete deletion of the STS gene. In a patient of 
XLI exhibiting a normal amplifying pattern with 
A pproximately 90% of X-linked ichthyosis (XLI) pa-tients have complete or partial deletion of the ste.roid sulfatase (STS) gene in the X chromosome in diverse races (Ballabio et a/, 1987; Bonifas el al, 1987; Ballabio e/ a/, 1989; Sugawara eta/, 1993; Nomura et 
a/, 1995). Only a few patients show a point mutation of the STS 
gene (Basler et al, 1992). STS gene deficiency is thus easily detected 
by using a polymerase chain reaction (PCR) technique (Ballabio el 
a/, 1990). We applied the PCR technique described by Ballabio et 
a/ (1990) to detect complete deletion of the STS gene in eight of 
nine Japanese XLI patients. One patient exhibited PCR amplifica-
tion of the STS gene. Analysis of PCR single-stranded conforma-
tion polymorphisms (PCR-SSCP) indicated the existence of a point 
mutation in exon 7 of the STS gene in tllis patient. Upon DNA 
sequencing of exon 7, we found a novel point mutation (GGA ---7 
TGA), where Gly becomes a stop codon. 
MATERIALS AND METHODS 
Patients The STS gene was studied in nine patients with typicaJ XLI who 
had already been diagnosed by detection of the STS enzyme activity in 
leukocytes . 
PCR Mononuclear cells were separated from 4 ml of anticoagulated 
peripheral blood. Genomic DNA was isolated from the mononuclear cells 
by using SepaGene (Sanko Junyaku, Tokyo). 
Two sets of primers were designed as described by BaUabio eta/ (1990) to 
amplify the 292-bp DNA fragment located approximately 900 bp upstream 
from the initiation site of the STS gene (set 1) and the 363-bp DNA 
fragment containing the termination site in ex on 10 of the STS gene (set 2) . 
Three sets of primers were designed to amplify exon 7, exon 8, and exon 9 
as described by Basler eta/ (1992) . Sizes oLm1plified DNA fragments were 
158 bp, 178 bp, aod 140 bp in exon 7, exon 8, and exon 9, respectively. As 
a control for the PCR, human leukocyte antigen-C exon 2 was amplified in 
each case. 
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predicted sizes of the STS gene, a novel mutation was 
found resulting in the appearance of a stop codon in 
exon 7 of the STS gene. This suggests that exon 7 or 
an area in its downstream region is important for STS 
activity. J Invest Devmatol 109:244-245, 1997 
DNA amplification was performed as described by Ballabio et al (1990). 
The reaction conditions were denaturation at 94°C for 1 min, annealing at 
60°C for l min, and extension of 1 min at 72°C for 30 cycles in a DNA 
thermal cycler (Astec PC700, Fukuoka, Japan). After completion of the 
PCR, 9 f..d of the product was electrophoresed in 1.5% agarose gel 
containing ethidium bromide and photographed. 
SSCP Analysis SSCP analysis was performed as described by Orita el a/ 
(1989). PCR was performed with deo:>:ycytidine 5'-[a-32 P]triphosphate in 
the PCR buffer, and the internalJy labeled products were electrophoresed in 
6% polyacrylamide gel containing 10% glycerol. Autoradiography was done 
by exposure to x-ray film. 
DNA Sequencing Sequencing of the DNA fragment amplified by the 
PCR was carried out by using the dideoxynucleotide method after subclon-
ing into pBiuescript plasmid (Sanger et a/, 1977). 
RESULTS 
To detect deletion of the STS gene, PCR amplification was done 
with two sets of primers (set 1 and set 2) in nine XLI patients. PCR 
amplification with either set failed to ampli.f)' the STS gene in eight 
of the nine XLI patients. ln the remaining patient, the STS gene 
was amplified in both set 1 and set 2 at the predicted sizes. We 
speculated that tllis patient had a point mutation of the STS gene. 
Because three types of point mutations have been reported in XLI 
patients located at exon 7, exon 8, and exon 9, (Basler el a/, 1992), 
we used three sets of primers to amplify these three areas of the STS 
gene. With these three sets of primers, the DNA components were 
amplifi ed to their predicted sizes, in this patient and in a healthy 
individual (Fig 1). SSCP analysis of these amplified DNA fragments 
revealed two bands in each exon. The mobilities of the bands in 
exon 7 of the patient were different from those of healthy individ-
uals (data not shown), indicating the existence of a point mutation 
in tllis exon. We then ligated the amplified DNA fragments 
corresponding to exon 7 into plasmids, transformed competent 
cells, and obtained the recombinant DNAs. Sequencing of these 
DNA fragments revea.led that a pair of DNA fragments contained a 
point mutation (GGA ~ TGA) at nucl eotide position 1236 (Fig 2) , 
indicating appearence of the stop codon. 
DISCUSSION 
XLI is a genetic disorder caused by STS deficiency (Shapiro et a/, 
1978). The STS gene is located at a distal short arm of the X 
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Figure 1. PCR of exon 7, exon 8, and exon 9 of the STS gene . M, 
DNA size marker cf>x174 Hnelfl; l-7, exon 7 of the patient; 2-7, exon 7 of 
a male control; 1-8, ex on 8 of the patient; 2-8, exon 8 of a male control; 
1-9, exon 9 of the patient; 2- 9, ex on 9 of a male control. 
chromosome at Xp22.3 (Tiepolo et a/, 1980). Studies on large 
numbers of patients with XLI have shown that, in more than 80%, 
the enzyme deficiency is due to large deletions involving the entire 
STS gene and flanking sequences (Ballabio eta/, 1989; Shapiro et a/, 
1989). Because most XLI patients have complete deletion of the 
STS gene, PCR amplification of both the 5' end and the 3' end of 
the STS gene is useful for screening the STS gene deficiency 
(Ballabio ef a/, 1990). STS gene deficiencies, however, are heter-
ogenous; some patients show on ly partial deletion of the STS gene, 
and a few have no more than a point mutation of the gene (Basler 
et al, 1992). In tlus study, we examined the STS gene in nine 
Japanese patients with XLI by PCR amplification described by 
Ballabio et a/ (1990) and found that e ight of the nine patients had 
complete deletion of the STS gene, in agreement with data that 
most Japanese XLI patients have complete deletion of the gene 
(Sugawara et a/, 1993). The one exception showed normal ampli-
ficati.on of the 5' end and 3' end of the STS gene, suggesting that 
a point mutation resulted in loss ofSTS activity. The STS gene that 
encodes the 62-kDa polypeptide contains 10 exons (Yen et a/, 
1987) . Basler e/ a/ (1992) identified point mutations in three patients 
with XLI: TGG ~ AGG at nucleotide position 1320 in exon 8, 
TGC ~ TAC at nucleotide position 1543 in exon 9, and TCG ~ 
TGG at nucleotide position 1226 in exon 7. We prepared three sets 
of primers to ampli£)• these three exons and found a point mutation 
(GGA ~ TGA) at exon 7, where the stop codon appeared. The 
position of mutation fmmd in our patient is quite close to those 
found i.n the patients described by Basler et al (1992), suggesting 
that the enzyn•e portion encoded in exon 7 and its downstream 
region is important for STS activity. In fact, among patients with 
XLI showing partial deletion of STS gene, most deletions have 
been found at the 3' end (Ballabio eta/, 1989; Nomura eta/, 1995), 
further suggesting the importance of tlus portion for STS activity, 
although one XLI patient was reported to have exhibited deletion 
of exons 2-5 (Shapiro et al, 1989). 
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Figure 2. DNA sequence showing the G --? T change in exon 7 of 
the STS gene, which introduces the stop codon. 
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